查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1720536

前列腺肥大症手术的全球市场 - 市场规模，占有率，趋势，产业分析:各类型，各终端用户，各地区 - 市场预测(2025年～2034年)

Benign Prostatic Hyperplasia Surgical Treatment Market Size, Share, Trends, Industry Analysis Report: By Type, End User, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2个工作天内

价格

预计到 2034 年，全球良性摄护腺增生手术市场规模将达到 211.9 亿美元。

良性摄护腺增生 (BPH) 手术市场专注于治疗良性摄护腺增生此常见疾病，通常会导致频尿、尿滞留和膀胱炎等症状。当药物治疗等保守治疗无法缓解症状时，就需要进行 BPH 手术。由于 BPH 盛行率的不断上升，尤其是在更容易罹患良性前列腺增生的老年男性中，BPH 手术市场呈现显着成长。对雷射治疗、经尿道前列腺电切术 (TURP) 和前列腺动脉栓塞术 (PAE) 等微创手术的需求日益增长，这极大地促进了良性前列腺增生手术市场的扩张。

能够改善患者预后（例如缩短復原时间、减少併发症和缩短住院时间）的手术技术的开发是市场成长的主要驱动力之一。此外，对良性前列腺增生 (BPH) 的认识和诊断水平的提高、医疗保健可及性的提高以及报销政策的完善也推动了市场需求。机器人辅助手术的引入和雷射手术的日益普及正在改变治疗格局，为患者提供更多选择，从而推动整个良性前列腺增生手术市场的成长。

市场动态也包括对门诊手术的日益偏好，这刺激了手术技术的创新。此外，一些地区可支配收入的增加也扩大了获得先进治疗的机会。人口老化和对以患者为中心的解决方案的日益关注为市场扩张提供了充足的机会。预计市场研发活动也将增加，以进一步优化治疗方案并推动基于价值的医疗保健。因此，市场预计将持续发展，为医疗保健行业的利益相关者提供充满希望的机会。

良性摄护腺增生 (BPH) 手术市场报告重点

按类型划分，雷射手术凭藉其精准度、微创性和短恢復时间，在 2024 年占据了显着的市场占有率。

按最终用户划分，家庭医疗保健在 2024 年占据了最大的市场占有率，这得益于患者越来越倾向于便捷且经济高效的治疗方案。

2024 年，由于 BPH 的高发病率和先进的医疗基础设施，北美占据了最大的市场占有率。

由于医疗保健可近性的提高和老年人口的增加，预计亚太地区的 BPH 治疗市场在预测期内将成长最快。

全球市场的主要参与者包括Allium，Alembic Pharmaceuticals Limited，Asahi Kasei Corporation，Asclepion Laser Technologies GmbH，Boston Scientific Corporation，Coloplast Group，Cook Medical，IPG Photonics Corporation，Karl Storz Se & Co.KG，Medifocus, Inc，Olympus Corporation，PNN Medical A/S，ProstaLund Ab，PROCEPT BioRobotics Corporation，Quanta System，Richard Wolf GmbH，SRS Medical，Teleflex Incorporated，Urologix, LLC.等。

本报告提供全球前列腺肥大症手术市场相关调查，目前市场动态的详细的考察，及未来市场成长相关分析。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 全球前列腺肥大症手术市场考察

  • 市场概况
  • BPH 手术市场动态
    • 驱动因素与机遇
      • 微创手术的普及率不断提高
      • 老年人口不断增加
    • 限制与挑战
      • 手术费用高昂
  • PESTEL分析
  • 前列腺肥大症手术市场用途趋势
  • 价值链分析

第5章 全球前列腺肥大症手术市场:各类型

  • 主要发现
  • 简介
  • 经尿道摄护腺切除术 (TURP)
  • 雷射手术
  • UroLift 手术
  • Rezum 手术
  • 机器人辅助水刀消融术
  • 摄护腺支架
  • 经尿道微波热疗 (TUMT)
  • 经尿道摄护腺针棘消融术 (TUNA)
  • 摄护腺动脉栓塞术 (PAE)
  • 其他手术

第6章 全球前列腺肥大症手术市场:各终端用户

  • 主要调查结果
  • 简介
  • 医院
  • 门诊病人手术中心，诊疗所
  • 居家医疗

第7章 全球前列腺肥大症手术市场:各地区

  • 主要调查结果
  • 简介
    • 前列腺肥大症手术市场分析:各地区(2020年～2034年)
  • 北美
    • 北美:各类型(2020年～2034年)
    • 北美:各终端用户(2020年～2034年)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各类型(2020年～2034年)
    • 欧洲:各终端用户(2020年～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他的欧洲
  • 亚太地区
    • 亚太地区:各类型(2020年～2034年)
    • 亚太地区:各终端用户(2020年～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他的亚太地区
  • 中东·非洲
    • 中东·非洲:各类型(2020年～2034年)
    • 中东·非洲:各终端用户(2020年～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他的中东·非洲
  • 南美
    • 南美:各类型(2020年～2034年)
    • 南美:各终端用户(2020年～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他的南美

第8章 竞争情形

  • 扩张和收购的分析
    • 扩大
    • 收购
  • 伙伴关係/合作/协定/公开

第9章 企业简介

  • Allium
  • Alembic Pharmaceuticals Limited
  • Asahi Kasei Corporation
  • Asclepion Laser Technologies GmbH
  • Boston Scientific Corporation
  • Coloplast Group
  • Cook Medical
  • IPG Photonics Corporation
  • Karl Storz Se & Co. KG
  • Medifocus, Inc.
  • Olympus Corporation
  • PNN Medical A/S
  • ProstaLund Ab
  • PROCEPT BioRobotics Corporatio
  • Quanta System
  • Richard Wolf GmbH
  • SRS Medical
  • Teleflex Incorporated
  • Urologix, LLC
Product Code: PM5490

The global benign prostatic hyperplasia surgical treatment market size is expected to reach USD 21.19 billion by 2034, according to a new study by Polaris Market Research. The report "Benign Prostatic Hyperplasia Surgical Treatment Market Size, Share, Trends, Industry Analysis Report: By Type, End User (Hospitals, Ambulatory Surgery Centers and Clinics, and Homecare Settings), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The benign prostatic hyperplasia (BPH) surgical treatment market focuses on addressing the medical condition of an enlarged prostate, which often leads to symptoms such as frequent urination, urinary retention, and bladder infections. Surgical treatments for BPH are necessary when conservative therapies like medications fail to alleviate symptoms. The market has seen notable growth, driven by an increasing incidence of BPH, especially among the aging male population, who are more susceptible to prostate enlargement. The rising demand for minimally invasive procedures, such as laser-based therapies, transurethral resection of the prostate (TURP), and prostate artery embolization (PAE), is significantly contributing to the benign prostatic hyperplasia surgical treatment market expansion.

Advancements in surgical technology, which offer improved patient outcomes with shorter recovery times, reduced complications, and minimal hospital stays, is one of the key factors fueling market development. Moreover, rising awareness and diagnosis of BPH, coupled with increased healthcare access and reimbursement policies, have propelled market demand. The introduction of robotic-assisted surgeries and the growing adoption of laser surgeries are transforming the treatment landscape, providing patients with more options and driving the overall benign prostatic hyperplasia surgical treatment market growth.

The market dynamics also include a growing preference for outpatient procedures, which has spurred innovation in surgical techniques. Additionally, rising disposable income in several regions is enabling greater access to advanced treatments. The market holds considerable opportunity for expansion as the population continues to age, with an increasing focus on patient-centric solutions. The market is also poised to witness more research and development efforts, further optimizing treatment options and promoting value-based care. Consequently, the market is expected to continue evolving, presenting promising opportunities for stakeholders involved in the healthcare industry.

Benign Prostatic Hyperplasia Surgical Treatment Market Report Highlights

In terms of type, the laser surgeries segment accounted for a significant market share in 2024 due to their precision, minimal invasiveness, and shorter recovery time.

Based on end user, the homecare settings segment accounted for the largest market share in 2024 due to growing patient preference for convenience and cost-effective treatment options.

In 2024, North America accounted for the largest market share due to the high prevalence of BPH and advanced healthcare infrastructure.

The Asia Pacific benign prostatic hyperplasia surgical treatment market is expected to witness the fastest growth during the forecast period due to increasing healthcare access and a rising elderly population.

Some of the global key market players are Allium; Alembic Pharmaceuticals Limited; Asahi Kasei Corporation; Asclepion Laser Technologies GmbH; Boston Scientific Corporation; Coloplast Group; Cook Medical; IPG Photonics Corporation; Karl Storz Se & Co. KG; Medifocus, Inc.; Olympus Corporation; PNN Medical A/S; ProstaLund Ab; PROCEPT BioRobotics Corporation; Quanta System; Richard Wolf GmbH; SRS Medical; Teleflex Incorporated; and Urologix, LLC.

Polaris Market Research has segmented the benign prostatic hyperplasia surgical treatment market report on the basis of type, end user, and region:

By Type Outlook (Revenue, USD Billion, 2020-2034)

  • Transurethral Resection of the Prostate (TURP)
  • Laser Surgeries
  • Urolift Procedures
  • Rezum Procedures
  • Robot-Assisted Waterjet Ablation
  • Prostatic Stents
  • Transurethral Microwave Thermotherapy (TUMT)
  • Transurethral Needle Ablation of the Prostate (TUNA)
  • Prostatic Arterial Embolization (PAE)
  • Other Procedures

By End User Outlook (Revenue, USD Billion, 2020-2034)

  • Hospitals
  • Ambulatory Surgery Centers and Clinics
  • Homecare Settings

By Regional Outlook (Revenue, USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Benign Prostatic Hyperplasia Surgical Treatment Market Insights

  • 4.1. Benign Prostatic Hyperplasia Surgical Treatment Market - Market Snapshot
  • 4.2. Benign Prostatic Hyperplasia Surgical Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Adoption of Minimally Invasive Procedures
      • 4.2.1.2. Expanding Geriatric Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Costs of Surgery
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Benign Prostatic Hyperplasia Surgical Treatment Market Application Trends
  • 4.6. Value Chain Analysis

5. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Transurethral Resection of the Prostate (TURP)
    • 5.3.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Transurethral Resection of the Prostate (TURP), by Region, 2020-2034 (USD Billion)
  • 5.4. Laser Surgeries
    • 5.4.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Laser Surgeries, by Region, 2020-2034 (USD Billion)
  • 5.5. Urolift Procedures
    • 5.5.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Urolift Procedures, by Region, 2020-2034 (USD Billion)
  • 5.6. Rezum Procedures
    • 5.6.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Rezum Procedures, by Region, 2020-2034 (USD Billion)
  • 5.7. Robot-Assisted Waterjet Ablation
    • 5.7.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, Robot-Assisted Waterjet Ablation, by Region, 2020-2034 (USD Billion)
  • 5.8. Prostatic Stents
    • 5.8.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Prostatic Stents, by Region, 2020-2034 (USD Billion)
  • 5.9. Transurethral Microwave Thermotherapy (TUMT)
    • 5.9.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Transurethral Microwave Thermotherapy (TUMT), by Region, 2020-2034 (USD Billion)
  • 5.10. Transurethral Needle Ablation of the Prostate (TUNA)
    • 5.10.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Transurethral Needle Ablation of the Prostate (TUNA), by Region, 2020-2034 (USD Billion)
  • 5.11. Prostatic Arterial Embolization (PAE)
    • 5.11.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Prostatic Arterial Embolization (PAE), by Region, 2020-2034 (USD Billion)
  • 5.12. Other Procedures
    • 5.12.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Other Procedures, by Region, 2020-2034 (USD Billion)

6. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by End User

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Hospitals, by Region, 2020-2034 (USD Billion)
  • 6.4. Ambulatory Surgery Centers and Clinics
    • 6.4.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Ambulatory Surgery Centers and Clinics, by Region, 2020-2034 (USD Billion)
  • 6.5. Homecare Settings
    • 6.5.1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Homecare Settings, by Region, 2020-2034 (USD Billion)

7. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Benign Prostatic Hyperplasia Surgical Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Benign Prostatic Hyperplasia Surgical Treatment Market - North America
    • 7.3.1. North America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.3.2. North America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.3.3. Benign Prostatic Hyperplasia Surgical Treatment Market - U.S.
      • 7.3.3.1. U.S.: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.3.4. Benign Prostatic Hyperplasia Surgical Treatment Market - Canada
      • 7.3.4.1. Canada: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.4. Benign Prostatic Hyperplasia Surgical Treatment Market - Europe
    • 7.4.1. Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.3. Benign Prostatic Hyperplasia Surgical Treatment Market - UK
      • 7.4.3.1. UK: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.4. Benign Prostatic Hyperplasia Surgical Treatment Market - France
      • 7.4.4.1. France: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Germany
      • 7.4.5.1. Germany: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.6. Benign Prostatic Hyperplasia Surgical Treatment Market - Italy
      • 7.4.6.1. Italy: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.7. Benign Prostatic Hyperplasia Surgical Treatment Market - Spain
      • 7.4.7.1. Spain: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.8. Benign Prostatic Hyperplasia Surgical Treatment Market - Netherlands
      • 7.4.8.1. Netherlands: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.9. Benign Prostatic Hyperplasia Surgical Treatment Market - Russia
      • 7.4.9.1. Russia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.4.10. Benign Prostatic Hyperplasia Surgical Treatment Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Asia Pacific
    • 7.5.1. Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.3. Benign Prostatic Hyperplasia Surgical Treatment Market - China
      • 7.5.3.1. China: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.4. Benign Prostatic Hyperplasia Surgical Treatment Market - India
      • 7.5.4.1. India: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Malaysia
      • 7.5.5.1. Malaysia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.6. Benign Prostatic Hyperplasia Surgical Treatment Market - Japan
      • 7.5.6.1. Japan: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.7. Benign Prostatic Hyperplasia Surgical Treatment Market - Indonesia
      • 7.5.7.1. Indonesia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.8. Benign Prostatic Hyperplasia Surgical Treatment Market - South Korea
      • 7.5.8.1. South Korea: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.9. Benign Prostatic Hyperplasia Surgical Treatment Market - Australia
      • 7.5.9.1. Australia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.5.10. Benign Prostatic Hyperplasia Surgical Treatment Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.6. Benign Prostatic Hyperplasia Surgical Treatment Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.6.3. Benign Prostatic Hyperplasia Surgical Treatment Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.6.4. Benign Prostatic Hyperplasia Surgical Treatment Market - UAE
      • 7.6.4.1. UAE: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.6.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Israel
      • 7.6.5.1. Israel: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.6.6. Benign Prostatic Hyperplasia Surgical Treatment Market - South Africa
      • 7.6.6.1. South Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.6.7. Benign Prostatic Hyperplasia Surgical Treatment Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • 7.7. Benign Prostatic Hyperplasia Surgical Treatment Market - Latin America
    • 7.7.1. Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.7.3. Benign Prostatic Hyperplasia Surgical Treatment Market - Mexico
      • 7.7.3.1. Mexico: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.7.4. Benign Prostatic Hyperplasia Surgical Treatment Market - Brazil
      • 7.7.4.1. Brazil: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.7.5. Benign Prostatic Hyperplasia Surgical Treatment Market - Argentina
      • 7.7.5.1. Argentina: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
    • 7.7.6. Benign Prostatic Hyperplasia Surgical Treatment Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Allium
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Alembic Pharmaceuticals Limited
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Asahi Kasei Corporation
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Asclepion Laser Technologies GmbH
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Boston Scientific Corporation
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Coloplast Group
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Cook Medical
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. IPG Photonics Corporation
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Karl Storz Se & Co. KG
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Medifocus, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Olympus Corporation
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. PNN Medical A/S
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development
  • 9.13. ProstaLund Ab
    • 9.13.1. Company Overview
    • 9.13.2. Financial Performance
    • 9.13.3. Product Benchmarking
    • 9.13.4. Recent Development
  • 9.14. PROCEPT BioRobotics Corporatio
    • 9.14.1. Company Overview
    • 9.14.2. Financial Performance
    • 9.14.3. Product Benchmarking
    • 9.14.4. Recent Development
  • 9.15. Quanta System
    • 9.15.1. Company Overview
    • 9.15.2. Financial Performance
    • 9.15.3. Product Benchmarking
    • 9.15.4. Recent Development
  • 9.16. Richard Wolf GmbH
    • 9.16.1. Company Overview
    • 9.16.2. Financial Performance
    • 9.16.3. Product Benchmarking
    • 9.16.4. Recent Development
  • 9.17. SRS Medical
    • 9.17.1. Company Overview
    • 9.17.2. Financial Performance
    • 9.17.3. Product Benchmarking
    • 9.17.4. Recent Development
  • 9.18. Teleflex Incorporated
    • 9.18.1. Company Overview
    • 9.18.2. Financial Performance
    • 9.18.3. Product Benchmarking
    • 9.18.4. Recent Development
  • 9.19. Urologix, LLC
    • 9.19.1. Company Overview
    • 9.19.2. Financial Performance
    • 9.19.3. Product Benchmarking
    • 9.19.4. Recent Development

List of Tables:

  • Table 1 Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 3 North America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 4 North America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 5 U.S.: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 6 U.S.: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 7 Canada: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 8 Canada: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 9 Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 10 Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 11 UK: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 12 UK: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 13 France: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 14 France: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 15 Germany: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 16 Germany: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 17 Italy: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 18 Italy: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 19 Spain: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 20 Spain: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 21 Netherlands: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 22 Netherlands: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 23 Russia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 24 Russia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 25 Rest of Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Rest of Europe: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 27 Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 28 Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 29 China: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 30 China: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 31 India: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 32 India: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 33 Malaysia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 34 Malaysia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 35 Japan: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 36 Japan: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 37 Indonesia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Indonesia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 39 South Korea: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 40 South Korea: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 41 Australia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 42 Australia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 43 Rest of Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 44 Rest of Asia Pacific: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 45 Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 46 Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 47 Saudi Arabia: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 48 Saudi Arabia: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 49 UAE: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 50 UAE: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 51 Israel: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 52 Israel: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 53 South Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 54 South Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 55 Rest of Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Rest of Middle East & Africa: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 57 Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 58 Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 59 Mexico: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 60 Mexico: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 61 Brazil: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Brazil: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 63 Argentina: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 64 Argentina: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Benign Prostatic Hyperplasia Surgical Treatment Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by End User
  • Figure 9. Global Benign Prostatic Hyperplasia Surgical Treatment Market, by End User, 2024 & 2034 (USD Billion)